期刊
CELL REPORTS
卷 3, 期 5, 页码 1422-1429出版社
CELL PRESS
DOI: 10.1016/j.celrep.2013.04.013
关键词
-
类别
资金
- American-Italian Cancer Foundation (AICF) post-doctoral research fellowship
- European Molecular Biology Organization (EMBO) long-term fellowship
- Muscular Dystrophy Association (MDA) Development Award
- NIH [DA020812, NS065053, NS078007]
Axon degeneration is an evolutionarily conserved process that drives the loss of damaged axons and is an early event in many neurological disorders, so it is important to identify the molecular constituents of this poorly understood mechanism. Here, we demonstrate that the Phr1 E3 ubiquitin ligase is a central component of this axon degeneration program. Loss of Phr1 results in prolonged survival of severed axons in both the peripheral and central nervous systems, as well as preservation of motor and sensory nerve terminals. Phr1 depletion increases the axonal level of the axon survival molecule nicotinamide mononucleotide adenyltransferase 2 (NMNAT2), and NMNAT2 is necessary for Phr1-dependent axon stability. The profound long-term protection of peripheral and central mammalian axons following Phr1 deletion suggests that pharmacological inhibition of Phr1 function may be an attractive therapeutic candidate for amelioration of axon loss in neurological disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据